Skip to main content
logo
Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
6.52
-0.13 (-1.95%)
Apr 10, 2026, 1:28 PM EDT - Market open

Unicycive Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
1651289030831
Market Cap Growth
149.42%41.16%199.62%266.78%-73.38%-
Enterprise Value
126.6886.3364.3720.937.7714.47
Last Close Price
6.525.777.948.685.4020.60
PE Ratio
--3.46-1.41-0.68-0.45-2.40
PS Ratio
---44.698.65-
PB Ratio
4.874.2312.16-7.92-17.651.87
P/TBV Ratio
3.653.047.16-5.59-17.451.46
P/FCF Ratio
--4.07-3.16-1.65-0.53-5.33
P/OCF Ratio
--4.07-3.16-1.65-0.53-5.36
EV/Sales Ratio
---31.018.17-
EV/EBITDA Ratio
--2.98-2.03-1.02-0.43-1.61
EV/EBIT Ratio
--2.92-2.00-1.01-0.43-1.61
EV/FCF Ratio
--2.75-2.25-1.14-0.50-2.50
Debt / Equity Ratio
-00.02-0.1200.01
Debt / EBITDA Ratio
0.000.00-0.02-0.04-0.01-0.03
Debt / FCF Ratio
0.000.00-0.02-0.04-0.01-0.05
Net Debt / Equity Ratio
-1.36-1.36-3.432.340.64-0.99
Net Debt / EBITDA Ratio
1.421.420.800.440.021.82
Net Debt / FCF Ratio
1.311.310.890.490.022.81
Asset Turnover
-000.080.090
Quick Ratio
2.182.181.080.550.147.88
Current Ratio
2.592.591.280.760.818.75
Return on Equity (ROE)
-141.15%-141.14%-2028.11%1428.96%-225.47%-145.04%
Return on Assets (ROA)
-73.06%-73.06%-140.07%-244.27%-167.44%-94.75%
Return on Invested Capital (ROIC)
-859.83%-859.80%-4855.18%11904.87%6505.23%-28498.41%
Return on Capital Employed (ROCE)
-156.41%-156.40%-1527.56%1090.78%-223.24%-128.54%
Earnings Yield
-15.82%-28.94%-71.16%-147.47%-222.22%-41.75%
FCF Yield
-18.67%-24.56%-31.69%-60.64%-190.31%-18.76%
Buyback Yield / Dilution
-137.17%-137.17%-172.97%-62.98%-28.96%-37.37%
Total Shareholder Return
-137.17%-137.17%-172.97%-62.98%-28.96%-37.37%
Updated Mar 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q